No events are scheduled in this topic at this time. Click the RSS icon above and bookmark our RSS feed to learn about future events.
Monday, November 4, 2013 | 8:30 AM - 5:00 PM
Speakers: Anirban Banerjee (National Institute of Child Health and Human Development, NIH), Carole A. Bewley (National Institute of Diabetes and Digestive and Kidney Diseases, NIH), Pierre Escoubas (VenomeTech), Bryan Fry (The University of Queensland, Australia), Mandë Holford (Hunter College, CUNY / American Museum of Natural History), Inés Ibañez-Tallon (The Rockefeller University), Baldomero M. Olivera (University of Utah), Mark E. Siddall (American Museum of Natural History), Beatrix Ueberheide (NYU Langone Medical Center)
Panelists: Yvonne M. Angell (Ipsen), Les P. Miranda (Amgen), Hazel H. Szeto (Stealth Peptides Inc.)
Spiders, snakes, scorpions, sea snails and leeches produce over 10 million compounds offering great potential for venom-based drug discovery. This symposium investigates genomic, proteomic, and transcriptomic approaches to harness venom compounds.
Monday, October 21, 2013 | 8:30 AM - 5:00 PM
Speakers: Sean Hennessy (University of Pennsylvania), Philip Lazarus (Washington State University College of Pharmacy), A. David Rodrigues (Bristol-Myers Squibb), Robert A. Roth (Michigan State University), Andrea Gaedigk (Children's Mercy Hospital), Jack Uetrecht (University of Toronto), R. Scott Obach (Pfizer), Joseph A. Ware (Genentech), Ida S. Owens (National Institute of Child and Human Development, NIH)
Drug discovery involves assays to predict potential drug-drug interactions, and predicting clinical toxicity is complicated. This symposium examines in vivo, in vitro, and in silico approaches and explores their integration for evaluating human risk.
Wednesday, June 12, 2013 | 7:45 AM - 6:00 PM
Speakers: Martin J. Blaser (New York University School of Medicine), Sir Harry Burns (Scottish Government, Scotland), Patrice D. Cani (Université Catholique de Louvain, Belgium), Fred H. Degnan (King & Spalding LLP), Joël Doré (Institut National de la Recherche Agronomique, France), Jane A. Foster (McMaster University, Canada), Gary Frost (Imperial College London, United Kingdom), Patricia L. Hibberd (Harvard Medical School / Massachusetts General Hospital for Children), John Hutton (University of York, United Kingdom), Todd Klaenhammer (North Carolina State University), David A. Mills (University of California, Davis), Max Nieuwdorp (University of Amsterdam, The Netherlands), Bruno Pot (Institut Pasteur de Lille, France), Rowena Pullan (Pfizer Consumer Healthcare), Helen E. Raybould (University of California, Davis), Gregor Reid (Western University / Lawson Health Research Institute, Canada), David A. Relman (Stanford University School of Medicine), Andrew Serazin (Matatu LLC)
Explore research and policy strategies to translate scientific knowledge on the convergence of the microbiome, prebiotics, probiotics, and host physiology into nutritional and therapeutic applications for inflammation, obesity, diabetes, gastrointestinal disease, and malnutrition.
Friday, May 24, 2013 | 8:30 AM - 4:30 PM
Speakers: Scott A. Armstrong (Memorial Sloan-Kettering Cancer Center), Stephen Baylin (The Johns Hopkins University School of Medicine), Robert A. Copeland (Epizyme, Inc.), Vicki L. Goodman (GlaxoSmithKline), Haitao Li (Tsinghua University, China), X. Shirley Liu (Dana-Farber Cancer Institute), Robert Sims (Constellation Pharmaceuticals, Inc.), Alexander Tarakhovsky (The Rockefeller University)
Epigenetic research has shown that heritable changes in cancer cell transformation occur beyond the primary DNA sequence. This symposium reviews epigenetic regulators in cancer development and progress in designing therapies targeting the epigenome.
Organizers: Johanne Morne (New York State Department of Health AIDS Institute), Sonja Noring (New York State Department of Health AIDS Institute), Cheryl Smith (New York State Department of Health AIDS Institute), AIDS Institute Social Media Workgroup (New York State Department of Health AIDS Institute), Brooke Grindlinger (The New York Academy of Sciences), and Kerstin Hofmeyer (The New York Academy of Sciences)
This eBriefing looks at the impact of digital technologies on clinical care, especially for HIV and other sexually transmitted infections, exploring eHealth strategies for patient-centered care and clinical decision support.
Speakers: Eric Lai (Memorial Sloan-Kettering Cancer Center), Allison Abbott (Marquette University), Victor Ambros (University of Massachusetts Medical School), Gregory J. Hannon (Cold Spring Harbor Laboratories, Howard Hughes Medical Institute), Oliver Hobert (Columbia University Medical Center), and Gary Ruvkun (Massachusetts General Hospital and Harvard Medical School)
This eBriefing features Victor Ambros and Gary Ruvkun, recipients of the 2012 Dr. Paul Janssen Award for Biomedical Research for their role in the discovery of microRNA. Recent research on microRNA is also described.
Keynote Speakers: George Church (Harvard Medical School), Sean Hill (École Polytechnique Fédérale de Lausanne), Allan Jones (Allen Institute for Brain Science), Christof Koch (Allen Institute for Brain Science), and David Van Essen (Washington University in St. Louis)
One of the greatest challenges in neuroscience today is deciphering how the activity of neurons and circuits gives rise to higher order cognition and behavior. Researchers working at the forefront of systems and computational neuroscience discussed work to crack the neural code, describing advances in tools, technologies, imaging, informatics, and computational models for mapping neural networks.
Organizers: Steven Gross (Weill Cornell Medical College), Irwin Kurland (Albert Einstein College of Medicine), and Jennifer Henry (The New York Academy of Sciences)
The explosive rise in obesity and diabetes (diabesity) threatens the health of many in Western and in developing Asian countries. This eBriefing focuses on the discovery potential of metabolomics and other 'omics to elucidate the causes and effects of diabesity.
Translational Medicine Initiative
The Translational Medicine Initiative represents a three-year partnership between the New York Academy of Sciences and the Josiah Macy, Jr. Foundation to support the translation of basic science research into clinical applications.
Learn more at www.nyas.org/TransMed.